Cell MedX Corp. announced a private placement of 2,500,000 units at a price of $0.03 per unit for the gross proceeds of $75,000. Each unit sold under the offering consisted of one share in the common stock of the company and one share purchase warrant expiring on March 12, 2026.

Each warrant is exercisable for one additional share of the company?s common stock at a price of $0.04 per share on or before September 12, 2024, and at a price of $0.05 per share for the remaining life of the warrant. The transaction included participation from Amir Vahabzadeh, a director of the company and other individual investor acquiring a total of 1,000,000 Units for $30,000. The company received funding pursuant to exemption provided under Regulation D. The transaction will include participation from 2 investors.